| MR编号 | DK/H/1193/001 |
|---|
| 药品名称 | Medi-MIBI |
|---|
| 活性成分 | - Tetrakis(1-isocyan-2-methoxy-2-methylpropan)copper(1)-tetrafluoroborat 0.5 mg
|
|---|
| 剂型 | Radiopharmaceutical kit |
|---|
| 上市许可持有人 | Radiopharmacy Laboratory Ltd.
2040 Budaörs, Gyár st. 2.
Hungary |
|---|
| 参考成员国 - 产品名称 | Denmark (DK) |
|---|
| 互认成员国 - 产品名称 | - Luxembourg (LU)
- Cyprus (CY)
Medi-MIBI Kit for radiopharmaceutical preparation, 0.5 mg - Netherlands (NL)
Medi-MIBI 0,5 mg, Kit voor radiofarmaceutisch preparaat - Malta (MT)
Medi-Mibi Kit for Radiopharmaceutical Preparation 0.5mg - Portugal (PT)
- Slovenia (SI)
- Estonia (EE)
- Slovakia (SK)
- Greece (GR)
- Finland (FI)
- Austria (AT)
Medi-MIBI 500 Mikrogramm Kit für ein radioaktives Arzneimittel - Spain (ES)
- Italy (IT)
- Lithuania (LT)
- Latvia (LV)
- Norway (NO)
- Belgium (BE)
Medimibi 0,5 mg kit voor radiofarmaceutisch preparaat - Poland (PL)
Medi-MIBI - France (FR)
- Sweden (SE)
|
|---|
| 许可日期 | 2008/01/21 |
|---|
| 最近更新日期 | 2024/04/24 |
|---|
| 药物ATC编码 | - V09GA01 technetium (99mTc) sestamibi
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|